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Regulation of immunoglobulin (Ig) V(D)J gene rear-
rangement is dependent on higher-order chromatin
organization. Here, we studied the in vivo function
of the DNA-binding zinc-finger protein CTCF, which
regulates interactions between enhancers and pro-
moters. By conditional deletion of the Ctcf gene in
the B cell lineage, we demonstrate that loss of
CTCF allowed Ig heavy chain recombination, but
pre-B cell proliferation and differentiation was se-
verely impaired. In the absence of CTCF, the Igk light
chain locus showed increased proximal and reduced
distal Vk usage. This was associated with enhanced
proximal Vk and reduced Jk germline transcription.
Chromosome conformation capture experiments
demonstrated that CTCF limits interactions of the
Igk enhancers with the proximal Vk gene region and
prevents inappropriate interactions between these
strong enhancers and elements outside the Igk
locus. Thus, although Ig gene recombination can
occur in the absence of CTCF, it is a critical factor
determining Vk segment choice for recombination.
INTRODUCTION
Antigen receptor diversity of lymphocytes is achieved through
recombinase activating gene (RAG)-mediated DNA recombina-
tion of V (variable), D (diversity), and J (joining) gene segments
at the immunoglobulin (Ig) and T cell receptor (Tcr) loci in B
and T lymphocytes, respectively (Jung and Alt, 2004; Schlissel,
2003). The process of V(D)J recombination is regulated at
three different levels: lineage specificity, temporal order within
a lineage, and allelic exclusion.
B cells develop in the bone marrow (BM) through an orches-
trated network of transcription factors and signaling pathways(Nutt and Kee, 2007). Ig heavy-chain (Igh) V(D)J recombination
starts at the pre-pro-B cell stage with DH-to-JH rearrangement,
which precedes VH-to-DJH rearrangement in committed pro-B
cells. Productive Igh rearrangement leads to IgmH chain expres-
sion on the cell surface together with the surrogate light chain
(SLC) components l5 and VpreB as the precursor-B cell
receptor (pre-BCR). Signals from the pre-BCR and the inter-
leukin-7 receptor (IL-7R) drive proliferation of large pre-B cells
(Hendriks and Middendorp, 2004; Herzog et al., 2009). Upon
cessation of proliferation, pre-B cells undergo cellular differenti-
ation and transit to the small pre-B cell stagewhere Ig k or l light-
chain (Igl) VL-to-JL recombination is initiated (Herzog et al., 2009;
Schlissel, 2003). Productive Igl rearrangement results in surface
BCR expression and progression to immature B cells, which are
checked for autoreactivity before they leave the BM.
Mechanisms regulating V(D)J recombination are complex
and rely on developmental-stage specific changes in locus
accessibility to the RAG-recombinase (Jhunjhunwala et al.,
2009; Jung and Alt, 2004; Schlissel, 2003). They include subnu-
clear relocation, histone modifications, DNA demethylation,
germline transcription, antisense intergenic transcription, and
locus contraction mediated by looping of individual chromatin
domains. Accessibility is controlled by cis-regulatory elements
within the Ig loci, such as promoters, matrix attachment regions,
silencers, and enhancers, where binding of cell type-specific
transcription factors like Pax5, E2A, Ikaros, IRF4, or OBF-1
account for lineage- and developmental-stage specificity of
V(D)J recombination (Jhunjhunwala et al., 2009; Jung and Alt,
2004; Schlissel, 2003). Pax5 and Ikaros were shown to be
involved in Igh locus contraction and in their absence only the
DH proximal VH genes recombine (Fuxa et al., 2004; Reynaud
et al., 2008). Deletion of the transcription factor YY1 also pre-
vented Igh locus contraction, resulting in severely reduced
distal VH rearrangement (Liu et al., 2007). These studies indicate
that lineage-specific and ubiquitously expressed transcription
factors cooperate to establish higher-order chromatin struc-
tures that facilitate long-range interactions required for VH-DJH
or Vk-Jk rearrangement (Jhunjhunwala et al., 2008; Jhunjhun-
wala et al., 2009).Immunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc. 501
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CTCF Restricts Igk Enhancer InteractionsOne DNA-binding factor implicated in long-range interactions
is the CCCTC-binding factor (CTCF), a ubiquitously expressed
and highly conserved 11 zinc finger protein (Phillips and Cor-
ces, 2009). CTCF often controls specific interactions by pre-
venting inappropriate communication between neighboring
regulatory elements and/or independent chromatin domains,
in a developmentally regulated fashion. Gene insulation medi-
ated by CTCF may occur through the formation of chromatin
loop domains, as shown for the imprinted H19-Igf2 locus, the
mouse b-globin locus, and at boundaries of domains escaping
inactivation on the inactive X chromosome (Splinter et al., 2006;
reviewed in Phillips and Corces, 2009). In T helper 1 (Th1) cells,
CTCF cooperates with the Th1 cell lineage-specific transcrip-
tion factor T-bet for proper interferon-g (IFN-g) expression via
regulation of chromatin looping (Sekimata et al., 2009). We
recently showed that CTCF is also a critical regulator of cyto-
kine genes at the Th2 cytokine locus (Ribeiro de Almeida
et al., 2009).
A putative role for CTCF in Ig loci long-range interactions was
highlighted by the recent mapping of CTCF-binding sites across
the Ig loci (Degner et al., 2009; Ebert et al., 2011; Lucas et al.,
2011). TwoCTCF-binding sites in the Igh VH-DH intergenic region
were implicated in the control of lineage-specific and ordered
V(D)J recombination by separating the VH and DH regions
into distinct chromatin domains (Featherstone et al., 2010; Gial-
lourakis et al., 2010). CTCF sites flank recombination signal
sequences (RSSs) for many Igh proximal VH segments (Lucas
et al., 2011). In the distal VH region, CTCF and E2A were
shown to interact with Pax5-activated intergenic repeat (PAIR)
elements, which direct antisense transcription (Ebert et al.,
2011). Recently, knockdown of CTCF resulted in a modest
reduction in Igh locus contraction and increased antisense tran-
scription throughout the DH region and in distal VH segments
near PAIR elements (Degner et al., 2011).
Collectively, these data prompted us to investigate the in vivo
function of CTCF in B cell development. Here we show that
conditional Ctcf deletion in the B cell lineage still allowed for
the generation of cytoplasmic Igm expressing pre-B cells,
although they were severely hampered in proliferation and
cellular differentiation. For the Igk locus, we found preferential
recombination and increased germline transcription of proximal
Vk gene segments. Chromosome conformation capture assays
coupled to high-throughput sequencing (3C-Seq) (Soler et al.,
2010) revealed that CTCF limits interactions of k enhancers
with proximal Vk genes and prevents inappropriate interactions
between these strong enhancers and elements outside the Igk
locus.
RESULTS
Deletion of CTCF Ablates Early B Cell Development
To determine the function of CTCF in B cell development, we
crossed Ctcf floxed mice (Ctcffl/fl) (Heath et al., 2008) with
mb1-cre mice expressing Cre recombinase specifically in the
B cell lineage (Hobeika et al., 2006). Flow cytometric analyses
showed severely decreased proportions of B220+CD19+ B
lineage cells in the BM of mb1-cre Ctcffl/flmice, when compared
with wild-type (WT) controls (Figure 1A). Residual B-lineage cells
were mainly intracellular Igm pro-B cells, although a detectable502 Immunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc.fraction expressed intracellular Igm, indicating productive Igh
rearrangement (Figures 1A and 1B). An almost complete block
of early B cell development in mb1-cre Ctcffl/fl BM was evi-
denced by the lack of CD2+ small pre-B, immature B, and recir-
culating mature B cells (Figures 1A and 1B). B220+CD19+ cells
were virtually absent in mb1-cre Ctcffl/fl spleen or peritoneal
cavity (Figure 1C). Crosses of mb1-cre Ctcffl/fl mice with mice
carrying the antiapoptotic Em-Bcl2 transgene (Strasser et al.,
1991) demonstrated that the developmental block of CTCF-defi-
cient pre-B cells could not be explained by defective survival
only (see Figure S1 available online).
We used the LacZ reporter in the targeted Ctcf allele (Heath
et al., 2008) to evaluate the efficiency of deletion (Figure S1).
Consistent with previously reported highly efficient gene deletion
at the earliest stages of B cell development with mb1-cre mice
(Hobeika et al., 2006; Liu et al., 2007), Ctcf deletion occurred
already at the pre-pro-B cell stage (fraction A) (Hardy et al.,
1991) and was almost complete from the pro-B cell stage (frac-
tion B) onward (Figure 1D). Accordingly, CTCF mRNA and
protein were essentially undetectable in B220+CD19+ B lineage
fractions purified from mb1-cre Ctcffl/fl BM (Figures 1E and 1F).
These findings show that in mb1-cre Ctcffl/fl mice CTCF
expression is efficiently ablated in early stages of B cell develop-
ment and that CTCF is essential beyond the pre-B cell stage.
Defective Pre-B Cell Proliferation and Differentiation
in Mb1-Cre Ctcffl/fl Mice
The pre-BCR acts as a checkpoint that monitors functional Igh
rearrangement and induces, together with IL-7R signaling, clonal
expansion and survival of Igm+ large pre-B cells. Upon cessation
of proliferation, pre-BCR signals are additionally required for
developmental progression of large into small pre-B cells (Hen-
driks and Middendorp, 2004; Herzog et al., 2009).
Flow cytometric analysis of Igm+ pre-B cells from mb1-cre
Ctcffl/fl mice showed reduced cell size, indicating defective
proliferation (Figure 2A). Additionally, mb1-cre Ctcffl/fl pro-B
and large pre-B cells both showed decreased expression of
IL-7R a chain by flow cytometry (Figure 2A) and RT-PCR (Fig-
ure S2C). To directly examine the cell cycle status of B-lineage
cells in mb1-cre Ctcffl/fl mice, we measured DNA content by
propidium iodide staining. Although the proportions of cycling
pro-B cells were similar, we observed a considerable reduction
in the proportions of cycling large pre-B cells in mb1-cre Ctcffl/fl
mice, when compared with WT mice (26% versus 47%,
respectively, Figure 2B). Subsequently, we determined the
proliferation capacity in vivo by pulsing with a single dose of
the thymidine analog 5-bromodeoxyuridine (BrdU), which is
selectively incorporated into the DNA of cycling cells (Midden-
dorp et al., 2002). Flow cytometric analysis revealed comparable
proportions of BrdU+ pro-B cells, but a 50% reduction in the
fractions of BrdU+ large pre-B cells in mb1-cre Ctcffl/fl mice,
when compared with WT controls (Figure 2C).
Consistent with a strong pre-B cell arrest, the majority of
B220+CD19+ cells in mb1-cre Ctcffl/fl BM expressed the early
pro-B cell-specific markers c-Kit, CD43, and the SLC compo-
nent l5 and failed to upregulate CD2, CD25, and MHC class
II expression (Figure S2A). Quantitative RT-PCR analyses of
purified B220+CD19+CD2 cells from WT and mb1-cre Ctcffl/fl
BM showed proper specification and commitment to the
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Figure 1. Impaired B Cell Development in Mb1-Cre Ctcffl/fl Mice
(A) Flow cytometric analysis of WT and mb1-cre Ctcffl/fl total BM cells for expression of B220 and CD19 (top). B220+CD19+ B cell fractions were gated and
analyzed for intracellular Igm-CD2 (middle) or IgM-IgD (bottom). Data are representative of 14–28 mice per genotype. Numbers in dot plots indicate the
percentages of cells in each gate.
(B) Proportions of cells in live gate were calculated for pro-B (CD2 intracellular Igm), large pre-B (CD2 intracellular Igm+) and total small pre-B, immature B, and
recirculating mature B cell fractions (CD2+ intracellular Igm+) in BM of WT and mb1-cre Ctcffl/fl mice (mean and standard deviation [SD], *p < 0.001).
(C) CD19/B220 flow cytometry profiles of WT and mb1-cre Ctcffl/fl spleen (Sp) and peritoneal cavity (PC) lymphoid fractions. Dot plots are representative of 6–7
mice per genotype.
(D) Flow cytometric lacZ expression analysis of BM cells of the indicated mice. Results are shown as histogram overlays within three subsets: fraction A
(LinB220+CD19HSA/loCD43+), fraction B (CD19+CD43+BP-1HSA+), and fraction C+C’ (CD19+CD43+BP-1+HSA+/high).
(E and F) Purified B220+CD19+CD2 pro-B or large pre-B cells from BM of the indicated mice were analyzed by quantitative RT-PCR (E) or immunoblotting (F).
Ctcf expression levels were normalized to the levels of Gapdh, whereby the values in WT cells were set to one (mean and SD, for 3 pools of 6–7 mice per
genotype). Nuclear protein lysates were analyzed by immunoblotting for CTCF and Lsd1 as a protein loading control (2 pools of 6–7 mice per genotype). See also
Figure S1.
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CTCF Restricts Igk Enhancer InteractionsB cell fate, given that CTCF-deficient cells still expressed the
early B lineage genes Tcfe2a, Ebf1, Pax5, Il7ra, Cd79a, and
Cd79b, albeit often at slightly reduced levels (Figure S2A). For
genes that are normally up or downregulated upon pre-BCR
signaling (Igll1, Vpreb1 Irf4, Ikzf1) expression levels in CTCF-
deficient B220+CD19+CD2 cells were between those in
Rag1/ and WT fractions (Figure S2A), indicating that pre-
BCR signaling was not completely abrogated in the absence
of CTCF.
Genome-wide expression profiling of purified and CTCF-defi-
cient CD2 B220+CD19+ fractions (containing pro-B and pre-B
cells) revealed that 174 genes were differently expressed.
Approximately 50% of these genes demonstrated a pro-B cell
signature for CTCF-deficient B cell precursors, given that these
genes were also differentially expressed between Rag1/ pro-
B cells and VH81X Igh transgenicRag1
/ pre-B cells (Figure 2D;
Table S1). Other genes were upregulated in the absence of
CTCF, irrespective of B cell differentiation stage (Figure 2E;
Table S2).In summary, our findings show that CTCF-deficient cyto-
plasmic Igm+ pre-B cells manifested defective proliferation and
a severe block of cellular differentiation.
Igh V(D)J Rearrangement Occurs in CTCF-Deficient
Pro-B Cells
The presence of intracellular Igm+ pre-B cells in mb1-cre Ctcffl/fl
BM indicated successful Igh gene rearrangement in the absence
of CTCF. In addition, RT-PCR analysis revealed normal levels
of VHJ558, VH7183, and Im germline transcripts in B220
+CD19+
CD2 fractions frommb1-cre Ctcffl/flmice, suggesting unaltered
Igh locus accessibility (Schlissel, 2003) (Figures S2D and S2E).
We used quantitative RT-PCR to compare VH family usage
(Fuxa et al., 2004) in purified B220+CD19+CD2 fractions from
WT and mb1-cre Ctcffl/fl mice. We included mMT mice harboring
a targeted deletion of the Igm membrane exon (Kitamura et al.,
1991) as a control because they parallel CTCF-deficient mice
in that pre-BCR-induced proliferative expansion and concomi-
tant selection for particular VH segments in the context of theImmunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc. 503
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Figure 2. Defective Pre-B Cell Proliferation and Differentiation in Mb1-Cre Ctcffl/fl Mice
(A) Flow cytometric analysis of WT and mb1-cre Ctcffl/fl B220+CD19+ pro-B cells (CD2 intracellular Igm) and large pre-B cells (CD2 intracellular Igm+) for cell
size (forward side scatter [FSC]) and IL-7Ra. Results are displayed as histogram overlays (4–6 mice per genotype).
(B) Propidium iodide (PI) cell cycle analysis of B220+CD19+ pro-B cells (CD2 intracellular Igm) and large pre-B cells (CD2intracellular Igm+) purified from WT
and mb1-cre Ctcffl/fl BM. Percentages of cells in cycle (S/G2/M; >2N DNA content) are shown (representative of two mice per genotype).
(C) In vivo proliferation analysis of WT and mb1-cre Ctcf fl/fl B220+CD19+ pro-B cells (CD2 intracellular Igm) and large pre-B cells (CD2 intracellular Igm+). Mice
were i.p. injected with a single dose of BrdU and after 4 hr, the percentages of BrdU+ cells were determined by flow cytometry (mean values and SD for 3–4 mice
per genotype; *p < 0.001).
(D and E) DNA microarray analysis of total mRNA from purified B220+CD19+CD2 pro-B/large pre-B cell fractions in WT and mb1-cre Ctcffl/fl mice. Genes
differentially expressed between the two genotypes were subdivided into two groups: genes in which expression did (D) or did not differ (E) between control
Rag1/ pro-B cell and VH81X Rag1
/ pre-B cell fractions. Heatmaps for the 30 genes with highest fold change in expression between WT and mb1-cre Ctcffl/fl
B cell progenitors are shown (for complete gene lists, see Tables S1 and S2). On the bottom is the logarithmic quantitative scale for gene expression (3–4 pools of
3–7 mice per genotype). See also Figure S2.
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CTCF Restricts Igk Enhancer Interactionspre-BCR (ten Boekel et al., 1997) is absent. We found that in the
absence of CTCF proximal (VH7183) as well as distal (VHJ558)
gene segments were used, whereby their relative usage was
close to that of mMT mice (Figure S2F). Thus, Igh gene recombi-
nation, even to distal VH gene segments, occurred in CTCF-defi-
cient pro-B cells.
A Productively Rearranged Igh Transgene Allows CTCF-
Deficient Cells to Develop beyond the Pre-B Cell Stage
The nearly complete developmental block observed in mb1-cre
Ctcffl/fl mice precluded the analysis of CTCF function past the504 Immunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc.pre-B cell stage. However, upon introduction of the functionally
pre-rearranged Igm transgene VH81X (Martin et al., 1997), B cell
differentiationwaspartially rescued:we foundsubstantial popula-
tions of CD2+ and surface IgM+ B-lineage cells in VH81Xmb1-cre
Ctcffl/fl BM (Figure 3A). Although the VH81X transgene did not
appear to rescue the proliferation defect of CTCF-deficient large
pre-Bcells (FiguresS3A–S3C), theproportionsof largepre-Bcells
in vivo were not significantly different between VH81X and VH81X
mb1-cre Ctcffl/fl BM (Figure 3B). Furthermore, we observed
a partial correction of the expression profiles of the developmen-
tally regulated markers c-Kit, CD43, CD2, CD25, MHC class II,
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Figure 3. B Cell Development in VH81X Transgenic Mb1-Cre Ctcf
fl/fl Mice
(A) Flow cytometric analysis of VH81X and VH81X mb1-cre Ctcf
fl/fl BM cells for the expression of B220/CD19 (top). Total B220+CD19+ B cell fractions were gated
and analyzed for expression of intracellular Igm/CD2 (middle) or IgM/IgD (bottom). Data are representative of 7–14 mice per genotype. Numbers in dot plots
indicate the percentages of cells in each gate.
(B) Proportions of cells in live gate were calculated for pro-B (CD2 intracellular Igm), large pre-B (CD2 intracellular Igm+), small pre-B (CD2+IgM) and immature
B/recirculating mature B cell (CD2+IgM+) fractions in the BM of VH81X and VH81X mb1-cre Ctcf
fl/fl mice (mean values and SD, *p < 0.001).
(C) Flow cytometric analysis of gated B220+CD19+CD2+ cells from VH81X and VH81X mb1-cre Ctcf
fl/fl BM for the expression of IgM/ intracellular Igk. Data are
representative of 13–14 mice per genotype.
(D) Total RNA isolated from purified B220+CD19+CD2+ IgM (small pre-B cells) and IgM+ (immature/recirculating mature B cells) populations from VH81X and
VH81X mb1-cre Ctcf
fl/fl BM was analyzed by quantitative RT-PCR for Ctcf expression. Ctcf expression levels were normalized to the levels of Gapdh mRNA,
whereby the values in VH81X cells were set to one (mean values and SD, for three pools of six to seven mice per genotype). See also Figure S3.
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CTCF Restricts Igk Enhancer Interactionsand l5 (Figure S3D). VH81X mb1-cre Ctcf
fl/fl BM manifested
decreased proportions of CD2+ small pre-B cells, immature and
recirculating mature IgM+ B cells, when compared with VH81X
controls (Figures 3A and 3B). However, intracellular Igk L chain
expression in surface IgM small pre-B cells and IgM+ immature
B cells was quite similar in the two groups of mice (Figure 3C).
The reduced size of the small pre-B and immature B cell pop-
ulation in VH81Xmb-1-creCtcf
fl/flBMprompted us to investigate
the kinetics of the developmental progression of pre-B cells
in vivo by BrdU injection. We found only a minor developmental
delay of 1.5 hr in CTCF-deficient VH81X Igk+ immature B cells
(12 hr), compared with VH81X controls (10.5 hr, Figures S3E
and S3F). B220lowCD19+ B cells were detected in the spleen at
low numbers but were absent in peritoneal cavity of VH81X
mb1-cre Ctcffl/fl mice (Figure S3G). As assessed by quantitative
RT-PCR, CTCF mRNA was strongly reduced in B220+CD19+
subsets purified from VH81X mb1-cre Ctcf
fl/fl BM (Figure 3D).
Thus, expression of the VH81X transgene allowed significant
differentiation of CTCF-deficient cells beyond the large pre-B
cell stage.Increased Proximal Vk Gene and Reduced Jk Germline
Transcription in the Absence of CTCF
In small pre-B cells, successful Igl V-to-J recombination requires
that these gene segments are accessible to the recombination
machinery, which is reflected by germline transcription (Schlissel
and Baltimore, 1989) (Schlissel, 2003). We determined Igk and
Igl locus germline transcription in sorted CD2+ small pre-B cell
fractions by quantitative RT-PCR (Du¨ber et al., 2003; Inlay
et al., 2006). We found remarkably increased germline transcrip-
tion of the proximal Vk gene segment Vk3-7 in Ctcf-deficient
VH81X small pre-B cells, compared with VH81X controls (Fig-
ure 4A). Germline transcription of more distal Vk gene segments
was only slightly increased or not significantly different. In
contrast, germline transcripts initiating from promoters located
upstream of Jk (k
00.8, k01.1) (Grawunder et al., 1995) were
substantially reduced in the absence of CTCF (Figure 4A). Germ-
line transcription from the Jl1 and Jl3 clusters (l1
 and l3,
respectively (Engel et al., 1999) were increased, whereas Vl1,2
(Du¨ber et al., 2003) and l2 germline transcripts were not
affected (Figure 4A).Immunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc. 505
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Figure 4. Proximal Vk Usage in VH81X Transgenic Mb1-Cre Ctcf
fl/fl (pre-)B Cells
(A) Quantitative RT-PCR analysis for Igk and Igl locus germline transcription in purified B220+CD19+CD2+IgM small pre-B cell populations from VH81X and
VH81X mb1-cre Ctcf
fl/fl BM. Expression levels of different germline transcripts (GLTs) were normalized to the levels ofGapdh, whereby the values in VH81X small
pre-B cells were set to one. Data represent VH81X mb1-cre Ctcf
fl/fl mean values and SD for three independent pools of three to five mice.
(B) DNA sequencing analysis of Vk gene segment usage of nonproductive alleles from B220
+CD19+CD2+IgM small pre-B cell and B220+CD19+CD2+IgM+ (im)
mature B cell populations purified from VH81X and VH81X mb1-cre Ctcf
fl/fl BM. Genomic DNA was isolated and used for PCR amplification of Vk-Jk2 recom-
bination products, which were further cloned and analyzed by DNA sequencing. Data represent relative frequency of Vk usage per 0.2 Mbp intervals in the Igk
locus. A schematic representation of the Igk locus (top) shows the location of Vk genes in which germline transcription was analyzed in (A). Data are from three
independent pools of three to five mice per genotype (number of sequences analyzed: 35 sequences for VH81X B cells; 41 sequences for VH81Xmb1-cre Ctcf
fl/fl
B cells). See also Figure S4.
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CTCF Restricts Igk Enhancer InteractionsIn conclusion, loss of CTCF resulted in increased germline
transcription of the Vk proximal region and reduced k
0 germline
transcription over the Jk region in pre-B cells.Proximal Vk Usage in VH81X Transgenic CTCF-Deficient
B Cells
Next, we analyzed Vk gene usage by DNA sequencing of Vk-Jk
recombination products from purified pre-B and B cells. To
exclude repertoire effects of BCR-mediated selection, we first
focused on nonproductively rearranged alleles from control
(n = 35) and CTCF-deficient (n = 41) VH81X (pre-)B cells. We
calculated Vk gene usage for 100 kb intervals within the Igk
locus. In control VH81X (pre-)B cells, Vk usage was diverse and
for > 80% directed to the middle and distal regions of the Igk
locus (Figure 4B). Remarkably, in CTCF-deficient VH81X (pre-)
B cells, >50% of all Vk segments used were located in the
most proximal 200 kb region, exclusively containing members
of the Vk3 family. Importantly, this region was not used in control
VH81X (pre-)B cells (Figure 4B).
It is conceivable that CTCF indirectly controls Igk locus recom-
bination. CTCF might affect survival and thereby receptor edit-
ing, the process of ongoing Ig L chain recombination that serves
to replace autoreactive BCR specificities. However, when we
excluded cells that had performed receptor editing by analyzing
Vk gene usage in Jk1 recombination products only, we still506 Immunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc.observed increased Vk3 usage in CTCF-deficient cells (24 out
of 31, as compared with 0/14 in WT cells). We also found
that in the absence of CTCF both inversional and deletional
Ig k recombination events occurred (Figure S4A). Thus, reduced
receptor editing or specific defects in either inversional or dele-
tional recombination cannot explain the increased Vk3 usage
in the absence of CTCF. It remained possible that CTCF indi-
rectly controls Igk locus recombination through regulation of
other transcription factors, but we found that loss of CTCF did
not significantly affect the expression of nuclear proteins impli-
cated in Igk locus recombination (Schlissel, 2003), including
Tcfe2a, Id3, Ikzf3,, Irf4, Irf8, Pou2af1, Ccdn3, Rag1, and Rag2
(Figure S4B).
Taken together, these findings show that in the absence of
CTCF Vk-Jk recombination activity is preferentially targeted to
Vk3, consistent with the observed increased germline transcrip-
tion over the Vk proximal region.BCR-Mediated Selection Still Occurs in CTCF-Deficient
Immature B Cells
Detailed analysis of the Igk locus 1.0 Mbp proximal region
showed that in the absence of CTCF Vk usage in nonproductive
rearrangements was highly restricted to the Vk3 family, whereby
Vk3-4 was dominant (Figure 5A). Analysis of Vk-to-Jk1 rearrange-
ments yielded a similar distribution, showing that the observed
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Figure 5. Proximal Vk Repertoire in VH81X Transgenic mb1-cre
Ctcffl/fl (pre-)B Cells
DNA sequencing analysis of Vk gene segments used in total nonproductive Igk
alleles (A), nonproductive Vk-to-Jk1 alleles (B), productive Igk alleles from
B220+CD19+CD2+IgM small pre-B cells (C), and B220+CD19+CD2+IgM+ (im)
mature B cells (D) purified from VH81X and VH81X mb1-cre Ctcf
fl/fl BM. Data
represent relative frequency of individual Vk gene segments used for the
proximal 1 Mbp region of the Igk locus. In each panel, the x axis shows the
location of various Vk gene segments. Collective data are from three inde-
pendent pools of three to five mice per genotype (number of sequences
analyzed for VH81X and for VH81X mb1-cre Ctcf
fl/fl mice are for nonproductive
alleles: 35 and 41, respectively; for productive alleles in IgM small pre-B: 32
and 30; and for productive alleles in IgM+ B cells: 36 and 30. Some DNA
sequences cannot exclusively be assigned to a single Vk gene segment (see
8-19/8-28, 3-4/ 3-8 and 5-43/5-45 (marked with an asterisk).
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CTCF Restricts Igk Enhancer Interactionsdifferences between control and CTCF-deficient alleles were not
dependent on receptor editing events (Figure 5B). In addition,
productive alleles in CTCF-deficient cells manifested preferential
Vk3 usage (32/60 alelles, versus 0/60 in WT controls). HerebyVk3-10 and Vk3-7 segments were predominantly used in surface
IgM small pre-B cells and surface IgM+ B cells, respectively
(Figures 5C and 5D). The finding that relative frequencies of indi-
vidual Vk3 family members differed considerably between
productive and unproductive Igk alleles indicates that BCR-
mediated selection still occurred in the absence of CTCF. More-
over, the observed increased usage of Vk3 in the absence of
CTCF affected all Vk3 family members.
Vk Usage Is Correlated with CTCF-Binding Sites
in the Igk Locus
Next, we identified CTCF-binding sites in the Igk locus in
cultured primary pre-B cells using chromatin immunoprecipita-
tion coupled to high-throughput sequencing (ChIP-Seq) (Fig-
ure 6A). We identified predominant CTCF binding at the 50
and 30 boundaries of Igk locus, as well as at the SIS (silencer
in intervening sequence) recombination silencer element
residing in the Vk-Jk region (Liu et al., 2006), in agreement
with reported findings (Degner et al., 2009). The SIS element
has been shown to negatively regulate rearrangement and to
specify targeting to centromeric heterochromatin (Liu et al.,
2006). In contrast to the previously reported low density of
CTCF occupancy in the Igk locus (Degner et al., 2009), we found
60 CTCF-binding sites, which were not evenly distributed
throughout the Igk locus. We identified five regions with a high
density of CTCF sites (regions H1–H5, Figure 6A), and four
regions of 150–250 kb with low CTCF occupancy (regions L1–
L4, Figure 6A). These four regions, including the proximal region
containing Vk3-family segments (L4; pos. 0 to 250 kb), con-
tained 29 Vk gene segments, which were rarely used in WT
mice (only 1/35 nonproductive alleles). In contrast, regions H2
and H3 contain Vk gene segments that were frequently used
in WT mice (Figure 6B).
Because in the Igh locus proximal VH segments are frequently
associated with nearby CTCF sites (Lucas et al., 2011), we
examined CTCF occupancy and Vk segment localization. We
found that 26 of the 60 CTCF sites were located near (<5 kb)
a Vk gene segment (Figure 6A). Vk gene segments with nearby
CTCF sites were mainly present in the proximal half of the Igk
locus and were more often used in CTCF WT (9/35) than in
CTCF KO (1/41) nonproductive rearrangements.
In summary, we identified 60 CTCF-binding sites in the Igk
locus in pre-B cells. Four regions of 150–250 kb, including the
most proximal Vk region, lacked CTCF occupancy and Vk
segments in these regions were rarely used in WT Igk alleles.
Loss of CTCF Affects Interactions between the SIS
Element and the Proximal Vk Region
Because of the presence of a predominant CTCF peak at the
SIS element, we decided to determine genome-wide interactions
mediated by the SIS region in the presence and absence of
CTCF, using chromosome conformation capture coupled
to high-throughput sequencing (3C-seq) (Soler et al., 2010).
To ensure analysis of long-range interactions in non-rearranged
Igk loci, we crossed VH81X and VH81X mb1-cre Ctcf
fl/fl mice
on the Rag1/ background. Quantitative RT-PCR analysis of
Vkgermline transcription in sorted B220
+CD19+ pre-B cell frac-
tions confirmed that also on the Rag1/ background loss of
CTCF was associated with increased germline transcription ofImmunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc. 507
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Figure 6. The Igk Locus: Regions with High and Low CTCF Occupancy and the Effects of CTCF Deficiency on Long-Range Chromatin Inter-
actions
(A) Schematic representation of the Igk locus and CTCF-occupancy in pre-B cells, as determined by ChIP-Seq. Strong CTCF sites at the 30 and 50boundaries of
the locus (50B and 30B), as well as within the locus (H1-H5) are indicated. L1-L4 represent regions with low CTCF-occupancy.
(B) 3C-Seq analysis of long-range interactions with the SIS region in B220+CD19+ small pre-B cell populations purified from VH81X Rag1
/ and VH81X Rag1
/
mb1-cre Ctcffl/fl BM and total fetal liver cells. Cross-linked and BglII-digested DNA fragments were ligated and subsequently digested by NlaIII followed by re-
ligation. Viewpoint-specific primers on the fragment of interest (containing the SIS viewpoint) were used for generating 3C-Seq libraries (see Experimental
Procedures for details). The graph shows the number of reads per million in 0.1Mbp intervals in the 3.2Mb Igk locus (shaded area) plus 3.0Mbp upstream and 2.8
Mbp downstream genomic regions. The dashed line represents the viewpoint. 3C-Seq counts obtained for fragments adjacent to the viewpoints were excluded
from the analysis.
(C) Number of reads per million obtained for each of the 60 BglII fragments that cover the regions indicated in (B). In each graph, the x axis shows the location in
relation to the viewpoint (in Mb). See also Figure S5.
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CTCF Restricts Igk Enhancer Interactionsthe proximal Vk gene segment Vk3-7, compared with CTCF-ex-
pressing VH81X Rag1
/ pre-B cells (Figure S6). We purified
B220+CD19+ pre-B cell populations from control andCTCF-defi-
cient VH81X Rag1
/ BM and performed 3C-Seq experiments,
whereby we included E13.5 fetal liver cells as controls. To facili-508 Immunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc.tate direct comparison with Vk gene usage, we calculated the
number of interactions for 100 kb intervals within the Igk locus.
Figure 6B shows the long-range interactions identified within
a 9 Mb region encompassing the Igk locus and its flanking
regions.
Immunity
CTCF Restricts Igk Enhancer InteractionsIn VH81X Rag1
/ small pre-B cells, the SIS element showed
interactions throughout the Igk locus, also with regions located
at considerable distance (-3.2 Mbp). Major interactions were
found with regions H1–H5, for which we observed high CTCF
occupancy. On the other hand, signals were low for the regions
L1–L4, where CTCF occupancy was low. In contrast, in non-re-
arranging control fetal liver cells genomic contacts were reduced
to background levels throughout the Igk locus (Figure 6B).
Importantly, when we analyzed CTCF-deficient VH81X trans-
genic Rag1/ pre-B cells, we found that the interactions
between the SIS region and most of the Igk locus were not
different from those identified in CTCF-expressing pre-B cells.
Only at the proximal Vk region (0–300 kb, containing the L4
region) did the SIS region manifest significantly increased inter-
actions (Figure 6B), consistent with increased Vk usage in the
absence of CTCF. Detailed views of Vk regions with high levels
of interaction (H3 and H4) and of the proximal L4 region are
shown in Figure 6C.
In summary, these findings demonstrate long-range interac-
tions between the SIS-region and the entire Igk locus, whereby
regions with high numbers of identified contacts correlate with
the localization of prominent CTCF-binding sites. Nevertheless,
the long-range interactions in pre-B cells between the SIS and
Vk region were not notably affected by loss of CTCF; only in
the proximal Vk region did the loss of CTCF result in significantly
increased interactions.
CTCF Restricts the Activity of the Enhancer Elements
in the Igk Locus
CTCF is thought to function in spatial organization of chromatin
topology via loop formation, whereby the positioning of CTCF-
binding sites with respect to genes and regulatory elements
dictates the types of CTCF-based chromatin loop structures
formed (Phillips and Corces, 2009). As a result, CTCF-mediated
contacts may either confer enhancer blocking or may enable
promoter-enhancer interactions. In rearranged and actively tran-
scribed Igk alleles, long-range interactions between active Vk
gene promoters and the intronic and 30 enhancers (iEk and
30Ek) are essential for Vk-Jk recombination (Liu and Garrard,
2005). Therefore, we next investigated whether CTCF-mediated
looping controlled Vk-Jk recombination by regulating the spatial
proximity of Vk gene segments relative to the Igk enhancer
elements.
In 3C-seq experiments using the iEk and 30Ek enhancers as
viewpoints, the identified interactions in the Igk locus paralleled
those found for the SIS region, with clear peaks at the H1–H5
regions (Figures 7A and 7B). Although many long-range interac-
tions were preserved in the absence of CTCF, we observed an
altered distribution of enhancer contacts: increased interactions
with the most proximal part of the Vk region (H4 and H5 and
particularly L4; detailed analyses in Figures 7C and 7D) and
decreased distal interactions. In particular, 30Ek contacts near
the 50 boundary region, containing the two most distal Vk genes
(Vk2-137 and Vk1-135) often used in control (20%, Figure 4B)
but not in CTCF-deficient (pre-)B cells, were reduced (Figures
7B and 7D).
Loss of CTCF also changed interaction of the k enhancers
with regions outside the Igk locus. Beyond the 50 boundary of
the Igk locus, loss of CTCF was associated with increasediEk interactions at 4.2 Mbp (region O1) as well as with reduced
interactions at3.7Mbp (region O2) (Figures 7A and 7C). A large
region of 0.8 Mb, located downstream the 30 boundary of the
Igk locus (region O3) showed high amounts of interaction with
the k enhancers in CTCF-deficient pre-B cells (Figures 7A, 7B
and 7D).
Finally, to exclude the possibility that the observed interac-
tions in our 3C-Seq experiments were affected by the absence
of focal Rag1 binding to the Jk region (Ji et al., 2010), we also
performed 3C-Seq experiments for the iEk and 30Ek enhancer
viewpoints in sorted pre-B cells from VH81X and VH81X mb1-
cre Ctcffl/fl mice that were on a Rag1-proficient background. In
these analyses, we also found that in the absence of CTCF
contacts between the enhancers and the proximal Vk region or
regions outside the Igk locus were increased (Figure S6).
Taken together, these 3C-seq analyses revealed that interac-
tion between the SIS, Ek, and 30Ek elements and the Igk V region
did not require CTCF per se. The absence of CTCF significantly
increased the interactions between the enhancer elements and
the proximal Vk region and regions outside the Igk locus.
DISCUSSION
In this study, we used conditional Ctcf gene targeting to investi-
gate the function of CTCF during B cell development in vivo. We
found that CTCF was critical at the pre-B cell developmental
checkpoint, probably as a regulator of genes involved in prolifer-
ation and cellular differentiation, but V(D)J recombination still
occurred when the Ctcf gene was deleted. We studied the Igk
locus in detail and found that loss of CTCF resulted in (1)
increased proximal Vk and reduced Jk germline transcription,
(2) increased recombination to proximal Vk genes, (3) decreased
usage of more distal Vk genes, particularly of the two most distal
Vk genes, and (4) increased interactions of the iEk and 3
0Ek
enhancers with the proximal Vk region andwith elements outside
the Igk locus. Our 3C-seq experiments revealed that long-range
interactions between the SIS silencer, iEk or 30Ek elements and
the Igk V region did not require CTCF per se. Rather, we
conclude that CTCF is required for the specificity of interactions
between these regulatory elements and Vk segments, thereby
restricting Igk enhancer activity and controlling Vk gene segment
choice.
We demonstrated that in CTCF-deficient pre-B cells proximal
Vk genes are preferentially used for recombination, consistent
with increased germline transcription and increased iEk and/or
30Ek enhancer interactions with the Vk proximal region. In
contrast, germline k00.8/1.1 transcripts, initiated from promoters
located upstream of Jk, were considerably reduced. On the basis
of CTCF occupancy in the Igk locus and the observed long-range
interactions in the presence and absence of CTCF, we propose
a model (Figure S6). In this model, CTCF activity regulates Igk
locus recombination by orchestrating functional communica-
tions between Vk gene segments and enhancers, while limiting
the actions of Igk locus specific cis- and trans-acting factors
elsewhere in the genome. Strong CTCF-binding sites flanking
the Igk locus and in the SIS element in the Vk-Jk intergenic region
(Degner et al., 2009) would partition off the locus into three main
chromatin loop domains, separating the Jk-Ck cluster containing
the iEk-30Ek enhancers, the proximal part of the Vk region (withImmunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc. 509
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Figure 7. CTCF Restricts Intronic and 30 k Enhancer Interactions to the Igk Light Chain Locus
(A and B) 3C-Seq analysis of long-range interactions with the iEk (A) or 30Ek (B) region in B220+CD19+ small pre-B cell populations purified from VH81X Rag1
/
and VH81XRag1
/mb1-creCtcffl/flBMand total fetal liver cells. See legend to Figure 6 and Experimental Procedures for details. The graph shows the number of
reads per million in 0.1 Mbp intervals in the 3.2 Mb Igk locus (shaded area) plus 3.0 Mbp upstream and 2.8 Mbp downstream genomic regions. The dashed line
represents the viewpoint. 3C-Seq counts obtained for fragments adjacent to the viewpoints were not considered.
(C and D) Number of reads permillion obtained for each of the 60 BglII fragments that cover the regions indicated in (A) and (B). In each graph, the x axis shows the
location in relation to the viewpoint (in Mb). See also Figure S6.
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CTCF Restricts Igk Enhancer Interactionsonly Vk3 family segments) and the remaining central and distal
parts of the Vk region. Hence, CTCFwould prevent inappropriate
communication between the Igk enhancers and the promoters of
proximal Vk3 gene segments or genomic regions outside the Igk
locus. On the basis of our 3C-Seq experiments showing that in
the absence of CTCF most of the long-range interactions within
the Igk locus were conserved, we propose that loss of CTCF has
limited effects on the global architecture of the Igk locus, except
for the Vk3 region and the very distal V region containing Vk2-137
and Vk1-135 (Figure S6). CTCF-dependent chromatin looping of
the Jk-Ck cluster and the iEk/3
0Ek enhancers would also restrict
Vk3 transcription and ensure proper Jk germline transcription.
Consistent with this, deletion of the SIS element results in
reduced levels of k00.8/1.1 germline transcripts (Liu et al.,
2006). Very recently, it was shown that mice possessing a 3.7
kb targeted deletion of the SIS element, associated with reduced
occupancy of Ikaros and CTCF, display enhanced proximal Vk
usage (Xiang et al., 2011). Increased proximal Vk usage resulting
from loss of CTCF can therefore be attributed to the CTCF sites
present in the SIS element.
In our model, dynamic scanning of the Vk region for recombi-
nation would depend on further regulatory sub-loops bringing Vk
gene segments into close spatial proximity with the Jk-Ck cluster
containing the iEk-30Ek enhancers. Interestingly, recent data
demonstrate that the highly active chromatin region encompass-
ing the Jk segments exhibits focal RAG protein binding (Ji et al.,
2010). In this region, Vk gene segments compete for capture by
RAG proteins and therefore it is referred to as a recombination
center (Ji et al., 2010). Our finding that long-range interactions
between SIS or enhancer elements weremost prominent in parts
of the Igk locus with strong CTCF-binding sites suggest a func-
tion of CTCF in the control of the positioning of Vk segments rela-
tive to the Jk-Ck-enhancer region. However, we demonstrated
that iEk-30Ek-mediated interactions and recombination to distal
Vk regions can occur in the absence of CTCF, strongly suggest-
ing that CTCF is largely dispensable for Igk locus sub-loop
formation. It is conceivable that CTCF cooperates in a redundant
fashion with lineage-specific factors bound to the k enhancers
(such as E2A, Pax5 or IRF4) for cell-specific regulation of chro-
matin looping, as previously demonstrated in Th1 cells (Seki-
mata et al., 2009). CTCF could alternatively function to direct
local histone modifications at the Igk locus (Splinter et al.,
2006), and thereby target RAG protein binding. In this context,
CTCF may function to epigenetically mark the Igk locus in
specific regions at early stages, after which it is no longer essen-
tial for the actual recombination process. Nevertheless, in this
model loss of CTCF increases contacts between the Jk-Ck-
enhancer region and Vk3 elements, leading to altered recombi-
nation events and inappropriate proximal Vk usage (Figure S6).
Our data demonstrating that CTCF is not essential for
enhancer contacts with the majority of Vk gene segments is
consistent with our previous findings suggesting that CTCF is
not absolutely required for TCR-a or TCR-b chain rearrangement
in thymocytes (Heath et al., 2008). However, for the Igh chain
locus a role for CTCF as a regulator of V(D)J rearrangement
through the establishment of higher-order chromatin structures
has been hypothesized (Degner et al., 2011; Lucas et al., 2011;
Ebert et al., 2011). This would be supported by several lines of
evidence. First, shRNA-mediated CTCF knockdown increasesDH antisense transcription and decreases Igh locus compaction
and interactions between DH and the 3
0 regulatory region
(Degner et al., 2011). Second, CTCF binds to PAIR elements,
which are characterized by Pax5-dependent active chromatin,
in the distal VH cluster in pro-B cells (Ebert et al., 2011) and to
many proximal VH segments, remarkably within 200 bp of their
RSS sequences (Lucas et al., 2011). Third, CTCF-binding DNase
I-hypersensitive sites within the VH-DH intergenic region influ-
ence antisense transcription and lineage-specific V(D)J recombi-
nation (Featherstone et al., 2010; Giallourakis et al., 2010).
However, our findings would not support a model in which
CTCF is essential for V(D)J rearrangement, like previously shown
for Pax5, Ikaros, or YY1 (Fuxa et al., 2004; Liu et al., 2007; Rey-
naud et al., 2008). Previous studies have established that confor-
mational changes in Igh locus topology that localize VH regions
within close proximity of DJH elements occur in committed
pro-B cells (Jhunjhunwala et al., 2008). Upon virtually complete
deletion of CTCF protein at the pro-B cell stage in the mb1-cre
Ctcffl/fl mice, pre-B cells with productive Igh rearrangements
were still generated. Nevertheless, our finding that the introduc-
tion of a pre-rearranged Ig H chain transgene partially rescued
differentiation of CTCF-deficient pro-B cells would suggest
that loss of CTCF reduces the efficiency of Igh chain recombina-
tion. Although both proximal and distal VH segments can be used
in the absence of CTCF, it still remains possible that CTCF is
required for efficient recombination to particular VH segments.
Furthermore, we cannot formally exclude that even very low
levels of CTCF proteins are sufficient to occupy critical sites in
the Igh locus at the time of initiation of V(D)J recombination. It
is also conceivable that CTCF determines the establishment of
a higher-order chromatin structure at early stages in B lympho-
cyte specification, before the pro-B cell stage, when mb1-cre
mediatedCtcf gene deletion is not complete. This would be sup-
ported by the recent finding that CTCF and E2A already bind to
the PAIR elements in Pax5/ pro-B cells prior to Igh locus
contraction (Ebert et al., 2011). Because CTCF has the ability
to influence histone modifications (Splinter et al., 2006), further
experiments are required to investigate whether CTCF functions
to epigenetically mark the Igh locus and thereby control Igh loop-
ing in lymphoid progenitors.
In summary, our study identifies a role for CTCF in directing
functional communications between Igk enhancers and Vk
promoters in the Igk locus, thereby regulating Vk gene segment
repertoire and restricting the activity of the strong iEk-30Ek
enhancers to the Igk locus.
EXPERIMENTAL PROCEDURES
Mice
Ctcf floxed mice (Ctcffl/fl; C57BL/6) (Heath et al., 2008) and Rag1/ (Mom-
baerts et al., 1992), Em-Bcl2 (Strasser et al., 1991), mMT (Kitamura et al.,
1991), and VH81X (Martin et al., 1997) mice have been described previously.
Mice were bred and maintained in the Erasmus MC animal care facility under
specific pathogen-free conditions andwere used at 6–13weeks of age. Exper-
imental procedures were reviewed and approved by the Erasmus University
committee of animal experiments.
Flow Cytometry
Preparation of single-cell suspensions, monoclonal antibodies (mAbs) incuba-
tions, fluorescein di-b-D-galactopyranoside loading, in vivo BrdU-labeling,
and cell cycle analysis have been previously described (Heath et al., 2008;Immunity 35, 501–513, October 28, 2011 ª2011 Elsevier Inc. 511
Immunity
CTCF Restricts Igk Enhancer InteractionsMiddendorp et al., 2002; Ribeiro de Almeida et al., 2009). See Supplemental
Experimental Procedures for monoclonal antibodies.
Quantitative RT-PCR Analysis
Total RNA was extracted with the GeneElute mammalian total RNA miniprep
system (Sigma-Aldrich) and reverse-transcribed with SuperScript II reverse
transcriptase (Invitrogen). For cDNA amplification, Maxima Probe/ROX or
SYBR Green/ROX qPCR MasterMix (Fermentas) were used. Primers were
designed with the ProbeFinder software (Roche Applied Science) and probes
were from the Universal ProbeLibrary (Roche Applied Science) or designed
manually (Gapdh) and purchased from Eurogentec (See Supplemental Exper-
imental Procedures). Triplicate reactions were done for each cDNA sample.
Gene expression was analyzed with an ABI Prism 7300 Sequence Detector
and ABI Prism Sequence Detection Software version 1.4 (Applied Bio-
systems). Cycle-threshold levels were calculated for each gene and normal-
ized to values obtained for the endogenous reference gene Gapdh. For
assessment of the purity of the amplified products, standard agarose gel elec-
trophoresis or melting curve analysis were performed.
Immunoblot Analysis
Nuclear extracts were prepared as previously described (Ribeiro de Almeida
et al., 2009). In brief, cytoplasmic proteins were extracted on ice for 10 min
(in 10 mM/HEPES-KOH [pH = 7.9], 1.5 mM/MgCl2, 10 mM/KCl, 0.5 mM/DTT,
0.2 mM/PMSF). High-salt extraction of nuclear proteins was carried out on ice
for 5 min (in 20 mM/HEPES-KOH [pH = 7.9], 25%/glycerol, 420 mM/NaCl,
1.5 mM/MgCl2, 0.2 mM/EDTA, 0.5 mM/DTT, 0.2 mM/PMSF), followed by
centrifugation for removal of cellular debris. Blots were probed with anti-
CTCF (1:1500, Upstate), anti-Lsd1 (1:2000, Abcam) as an internal loading
control, and the secondary antibody swine anti-rabbit-HRP (1:3000, Dako).
Primary Ab incubation was done overnight at 4C in TBS containing 3% nonfat
dry milk and 0.05% Tween-20. Signal detection was performed with ECL
(Amersham Biosciences).
DNA Microarray Analysis
Biotin-labeled cRNA was hybridized to the Mouse Gene 1.0 ST Array (Affyme-
trix). Data were analyzed with the BRB-ArrayTools version 3.7.0 software
(National Cancer Institute) with Affymetrix CEL files obtained from GCOS
(Affymetrix). The RMA approach was used for normalization. Thresholds for
selecting important genes were set at a relative difference > 1.75. Changes
in gene expression patterns for mb1-cre Ctcffl/fl versus WT pro-/pre-B cells
were evaluated with Student’s t test (with random variance model) and were
considered significant with p < 0.001. Quantitative RT-PCR was performed
on selected genes identified by the microarray analysis to verify their expres-
sion levels.
Vk Gene Sequencing, ChIP Sequencing, and 3C Sequencing
See Supplemental Experimental Procedures in the Supplemental Information
for details of Vk gene usage analysis, ChIP-sequencing, and 3C-sequencing.
Statistical Analysis
To analyze statistical significance, we used a two-tailed Student’s t test.
p values < 0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.immuni.2011.07.014.
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